← All Topics / ade

FDA ADE reports for Milbemycin oxime — total reports, species & reaction breakdown

ade_milbemycin_oxime_adverse_events

ade 200 tok en 2026-07-21

Milbemycin oxime — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Milbemycin oxime is a veterinary active ingredient.

Total reports

Milbemycin oxime: 193925

Reports by species (top entries)

  • Dog 179119
  • Cat 559
  • Human 308
  • 13
  • Other Canids 10
  • Other 6

Top reported reactions (VEDDRA terms, top entries)

  • Emesis 43026
  • Vomiting 39181
  • Lethargy (see also Central nervous system depression in 'Neurological') 22021
  • Lack of efficacy (endoparasite) - heartworm 14080
  • UNPALATABLE 13788
  • Lack of efficacy - NOS 13057
  • Diarrhoea 10844
  • INEFFECTIVE, HEARTWORM LARVAE 9084
  • Lack of efficacy (ectoparasite) - flea 7654
  • Lack of efficacy (endoparasite) - hookworm 7561

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21